Literature DB >> 198058

Peripheral and autonomic neuropathy after treatment with perhexiline maleate.

D M Fraser, I W Campbell, H C Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 198058      PMCID： PMC1631946          DOI： 10.1136/bmj.2.6088.675-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Polyneuropathy after perhexiline maleate therapy.

Authors:  F Lhermitte; M Fardeau; F Chedru; J Mallecourt
Journal:  Br Med J       Date:  1976-05-22

2.  [Letter: 7 peripheral neuropathies after treatment by perhexiline maleate].

Authors:  M G Bousser; P Bouche; C Brochard; G Herreman
Journal:  Nouv Presse Med       Date:  1976-03-06

3.  A STUDY OF THE TOXICITY OF DIPHTHERIA BACILLI ISOLATED FROM IMMEDIATE CONTACTS.

Authors:  F W Hachtel; M S Bailey
Journal:  Am J Public Health (N Y)       Date:  1920-01

4.  A simple test of cardiac function based upon the heart rate changes induced by the Valsalva maneuver.

Authors:  A B Levin
Journal:  Am J Cardiol       Date:  1966-07       Impact factor: 2.778

5.  Clinical evaluation of perhexiline maleate in patients with angina pectoris.

Authors:  C J Burns-Cox; K P Chandrasekhar; H Ikram; T H Peirce; J Pilcher; C D Quinlan; J R Rees
Journal:  Br Med J       Date:  1971-12-04
  5 in total
  4 in total

1.  Perhexilline-induced neuropathy.

Authors:  D M Fraser; H C Miller
Journal:  Br Med J       Date:  1978-04-01

2.  Drug-induced peripheral neuropathies.

Authors:  Z Argov; F L Mastaglia
Journal:  Br Med J       Date:  1979-03-10

3.  Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium.

Authors:  Cher-Rin Chong; Nigel E Drury; Giovanni Licari; Michael P Frenneaux; John D Horowitz; Domenico Pagano; Benedetta C Sallustio
Journal:  Eur J Clin Pharmacol       Date:  2015-09-16       Impact factor: 2.953

Review 4.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.